secwatch.observer — SEC 8-K summary
======================================

Issuer:     Theravance Biopharma, Inc. (TBPH)
CIK:        0001583107
Form:       8-K
Filed at:   2025-12-08T23:59:59+00:00
Accession:  0001104659-25-119032
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Theravance holds ampreloxetine KOL event; AGM set for June 12, 2026
-------------------------------------------------------------------

- Virtual KOL investor event for ampreloxetine held Dec. 8, 2025; slide deck furnished as exhibit.
- 2026 Annual General Meeting scheduled for June 12, 2026 in Dublin, Ireland.
- Proxy materials will be filed with SEC and made available to shareholders prior to the meeting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1583107/000110465925119032/0001104659-25-119032-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1583107/000110465925119032/tm2532919d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-119032

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer